4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-020190
Chief of Clinical Operations sold 3,207 shares at an average $4.11 ($13,171)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Devlin Jodi Chief of Clinical Operations | 2026-03-11 | Sale | −1,162 | $4.13 | $4,799 | 99,409 | D |
| Devlin Jodi Chief of Clinical Operations | 2026-03-12 | Sale | −1,772 | $4.09 | $7,247 | 97,637 | D |
| Devlin Jodi Chief of Clinical Operations | 2026-03-16 | Sale | −273 | $4.12 | $1,125 | 97,364 | D |
| Open-market sales · 3,207 sh · avg $4.11 · $13,171 | |||||||
Loading xslF345X06/wk-form4_1774038352.xml…